Articles

Find an Article

Filter articles

Applied Filters

Showing 21 to 30 of 302 results

A patent attack on three fronts

India02-10-2018Neeti Wilson, Arpita Kulshreshtha and Gitika Suri

A recent case in India reveals the various ways in which pharmaceutical patents can be challenged, as Neeti Wilson, Arpita Kulshreshtha and Gitika Suri of Anand and Anand report.

IP and personalised medicine: a tailor-made approach

US27-09-2018

While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out.

Patenting polymorphs in Mexico

Mexico11-09-2018Lino Almazan-Monroy and Mariana Gonzalez-Vargas

Lino Almazan-Monroy and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril discuss how inventors seeking patents for polymorphs in Mexico can give themselves the best chance of success.

Boehringer v Teva: Italian court clarifies boundaries of Bolar privilege

Italy11-09-2018Gabriel Cuonzo and Luca Pellicciari

The Milan Court has issued an important ruling clarifying the rules governing the activities of active pharmaceutical ingredient manufacturers in Italy, as Gabriel Cuonzo and Luca Pellicciari of Trevisan & Cuonzo report.

Medtech M&A: integration is key

US04-09-2018

As the tide of M&A activity continues to rise across the life sciences industry, LSIPR speaks to Tracy MacNeal of Ximedica on what’s driving the trend and the pitfalls to be aware of.

Two new weapons for defending Hatch-Waxman litigation

US03-09-2018Mark Remus

Mark Remus of Brinks Gilson & Lione discusses two patent-related challenges for generic pharmaceutical companies and how they might be overcome.

LSIPR 50 2018: Frank Kalkbrenner

Germany28-08-2018

Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

LSIPR 50 2018: Craig Muir

US23-08-2018

Craig Muir was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

SPC export waiver: a long road ahead

EU23-08-2018Trevor Cook

The European Commission’s proposed export waiver for supplementary protection certificates is likely to face opposition and may be delayed by EU parliamentary changes, says Trevor Cook of WilmerHale.

LSIPR 50 2018: Brian Anderson

US22-08-2018

Brian Anderson was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

Showing 21 to 30 of 302 results

LSIPR